The forecast for antibacterial medicine sales in Germany from 2024 to 2028 shows a stable growth trend with values consistently at 12 and slightly increasing to 12.1 US Dollars PPP per capita in subsequent years. No significant variations are observed with an approximate CAGR of 0.2% over the projected period. Previously, the market in 2023 stood at a similar range, indicating a mature and stable market environment.
Future trends to watch include:
- Potential impacts of healthcare policy changes on antibiotic prescribing practices.
- Advancements in antibacterial technology and new product launches.
- Increased awareness and measures against antibiotic resistance.
